Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome
Česká gynekologie · 2021
DOI: 10.48095/cccg2021124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Česká gynekologie, 2021. Verfasst von Petr Hubka und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Ovarian Hyperstimulation Syndrome, Polycystic Ovary Syndrome.
Abstract (Originalsprache)
Overview Objective: To present current possibilities of the prevention and therapy of ovarian hyperstimulation syndrome (OHSS).
Methods
Literature and guidelines were researched.
Results
From the view of safety and prevention of OHSS, antagonistic protocol is suitable. Patients with syndrome of polycystic ovaries benefit from the use of metformin or letrozole that can be sufficient to induce ovulation. As a treatment of imminent OHSS, it is recommended to administer 0.5 mg of cabergoline per os daily as well as low molecular weight heparin subcutaneously in prophylactic dose and to maintain sufficient fluid intake. Diuretics are strongly discouraged to use. To maintain intravascular volume, drained ascites can be reintroduced.
Conclusion
We present a review of current literature and recommendations. Keywords: assisted reproduction – In vitro fertilization – ovarian hyperstimulation syndrome – prevention – therapy
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Hubka, P., Višňová, H., Sehnal, B., Lincová, M., & Zikán, M. (2021). Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome. Česká gynekologie. https://doi.org/10.48095/cccg2021124
Vancouver
Hubka P, Višňová H, Sehnal B, Lincová M, Zikán M. Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome. Česká gynekologie. 2021. doi:10.48095/cccg2021124
BibTeX
@article{Hubka2021,
author = {Hubka, Petr and Višňová, Hana and Sehnal, Borek and Lincová, Marcela and Zikán, Michal},
title = {Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome},
journal = {Česká gynekologie},
year = {2021},
doi = {10.48095/cccg2021124}
}
EUVIMED